Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Handberg

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
American Heart Journal|March 22, 2021
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trialEileen M Handberg, C Noel Bairey Merz, Rhonda M Cooper-Dehoff, et al.
Circulation. Cardiovascular Imaging|March 25, 2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome EvaluationLouise E J Thomson, Janet Wei, Megha Agarwal, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
International Journal of Cardiology|July 6, 2016
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in ratsDomenico G Della Rocca, Bradley J Willenberg, Yanfei Qi, et al.
European Heart Journal|November 29, 2015
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveC Noel Bairey Merz, Eileen M Handberg, Chrisandra L Shufelt, et al.
Clinical Cardiology|February 28, 2007
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)Timothy R Wessel, Christopher B Arant, Susan P McGorray, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
American Heart Journal|March 22, 2021
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trialEileen M Handberg, C Noel Bairey Merz, Rhonda M Cooper-Dehoff, et al.
Circulation. Cardiovascular Imaging|March 25, 2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome EvaluationLouise E J Thomson, Janet Wei, Megha Agarwal, et al.
American Heart Journal|December 30, 2019
Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD)Odayme Quesada, Ahmed AlBadri, Janet Wei, et al.
International Journal of Cardiology|July 6, 2016
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in ratsDomenico G Della Rocca, Bradley J Willenberg, Yanfei Qi, et al.
European Heart Journal|November 29, 2015
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserveC Noel Bairey Merz, Eileen M Handberg, Chrisandra L Shufelt, et al.
Clinical Cardiology|February 28, 2007
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)Timothy R Wessel, Christopher B Arant, Susan P McGorray, et al.
Contemporary Clinical Trials|July 27, 2025
Association of study visit interval length with follow-up completeness and adherence to assigned study drug dose: A randomized comparison of participants in the ADAPTABLE trialDennis I Narcisse, Jeff Whittle, Grace M Rhodes, et al.
The New England Journal of Medicine|May 17, 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular DiseaseW Schuyler Jones, Hillary Mulder, Lisa M Wruck, et al.
Pageof 11